Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Clopidogrel in Acute Ischemic Stroke
NCT03266731Unknown
- Sponsor
- Assiut University
- Start
- Jan 2018
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
01
Overview
Open-label trial of aspirin and clopidogrel in ischemic stroke and Transient Ischemic Attack (TIA), sponsored by Assiut University. Primary endpoint: Clinically significant neurologic deterioration at 24 hours. Status: unknown.
02
Drugs
aspirinclopidogrel
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT03266731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266731.